{"version":"1.0","provider_name":"PHR Legal | Posse Herrera Ruiz","provider_url":"https:\/\/phrlegal.com\/en\/","title":"COLOMBIA - PHR Legal | Posse Herrera Ruiz","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"dSxRWa0MnI\"><a href=\"https:\/\/phrlegal.com\/en\/legal-bulletin\/colombia-192\/\">COLOMBIA<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/phrlegal.com\/en\/legal-bulletin\/colombia-192\/embed\/#?secret=dSxRWa0MnI\" width=\"600\" height=\"338\" title=\"&#8220;COLOMBIA&#8221; &#8212; PHR Legal | Posse Herrera Ruiz\" data-secret=\"dSxRWa0MnI\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/phrlegal.com\/wp-includes\/js\/wp-embed.min.js\n<\/script>\n","thumbnail_url":"https:\/\/phrlegal.com\/wp-content\/uploads\/2020\/10\/IP-Destacada.jpg","thumbnail_width":690,"thumbnail_height":440,"description":"INVIMA ANNOUNCES NEW PROVISIONS TO IMPLEMENT RESOLUTION No. 1124 OF 2016 IN REGARDS TO THE BIODISPONIBILITY AND BIOEQUIVALENCE STUDIES  Through external circular DG 100-0175-17, the National Institute of Food and Drug Surveillance (INVIMA) developed the criteria and requirements for the Bioavailability and Bioequivalence studies in Colombia for the procedure implementations established in Resolution No. 1124 2016."}